Found: 20
Select item for more details and to access through your institution.
New molecular entity.
- Published in:
- Formulary, 2008, v. 43, n. 1, p. 10
- Publication type:
- Article
New biologic.
- Published in:
- Formulary, 2008, v. 43, n. 1, p. 10
- Publication type:
- Article
Pipeline preview.
- Published in:
- Formulary, 2008, v. 43, n. 1, p. 10
- Publication type:
- Article
New biologic.
- Published in:
- 2008
- Publication type:
- Journal Article
FDA actions in brief.
- Published in:
- Formulary, 2008, v. 43, n. 1, p. 11
- Publication type:
- Article
FDA actions in brief.
- Published in:
- 2008
- Publication type:
- Journal Article
Biologic treatment of RA associated with increased risk of nonmelanotic skin cancer and melanoma.
- Published in:
- Formulary, 2008, v. 43, n. 1, p. 12
- Publication type:
- Article
Safety.
- Published in:
- Formulary, 2008, v. 43, n. 1, p. 12
- Publication type:
- Article
Correction.
- Published in:
- 2008
- Publication type:
- Correction notice
Safety labeling updates & new warnings.
- Published in:
- 2008
- Publication type:
- Journal Article
Biologic treatment of RA associated with increased risk of nonmelanotic skin cancer and melanoma.
- Published in:
- 2008
- Publication type:
- Journal Article
Equivalent dosing of irbesartan, valsartan, and losartan identified through formulary switch at a Veterans Affairs medical center.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Equivalent dosing of irbesartan, valsartan, and losartan identified through formulary switch at a Veterans Affairs medical center.
- Published in:
- Formulary, 2008, v. 43, n. 1, p. 14
- By:
- Publication type:
- Article
Certolizumab pegol.
- Published in:
- Formulary, 2008, v. 43, n. 1, p. 22
- By:
- Publication type:
- Article
Certolizumab pegol.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Study results favor teriparatide over alendronate for treatment of glucocorticoid-induced osteoporosis.
- Published in:
- Formulary, 2008, v. 43, n. 1, p. 29
- Publication type:
- Article
Study results favor teriparatide over alendronate for treatment of glucocorticoid-induced osteoporosis.
- Published in:
- 2008
- Publication type:
- Journal Article
Bar coding helps improve patient safety.
- Published in:
- Formulary, 2008, v. 43, n. 1, p. 30
- By:
- Publication type:
- Article
Bar coding helps improve patient safety.
- Published in:
- 2008
- Publication type:
- Journal Article
Drug Watch.
- Published in:
- Formulary, 2008, v. 43, n. 1, p. 32
- Publication type:
- Article